Welldoc, founded in 2005 and headquartered in the United States, stands at the forefront of integrating AI into healthcare, with a strong emphasis on personalized and predictive solutions. Under the banner of "Healthcare-Ready AI," Welldoc's platform streamlines fragmented cardiometabolic data into actionable, clinically-validated insights.
Operating across a wide array of industries including AI, Analytics, Health Care, and Mobile, Welldoc aims to bridge the gap between patients, care teams, and healthcare partners. Their technology is particularly adept at transforming scattered health data into a cohesive, beneficial framework for better health management.
The company's most recent financial boost was a $7.50M Series B investment in March 2016, led by Johnson & Johnson Robotics and Digital Solutions. This investment underscores the strategic value and potential impact of Welldoc's solutions in digitizing and enhancing healthcare delivery.